Followers | 116 |
Posts | 13861 |
Boards Moderated | 0 |
Alias Born | 03/16/2014 |
Wednesday, April 10, 2024 10:29:17 AM
We ended 2023 with more than $100 million in cash, restricted cash, cash equivalents and investments. Based on our current cash position and operational plans, we believe our financial resources are sufficient to fund the Company’s operations through the filing of a Biologics License Application (BLA) for efzofitimod in pulmonary sarcoidosis."
$LIFE
Recent LIFE News
- aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update • GlobeNewswire Inc. • 05/02/2024 08:00:00 PM
- aTyr Pharma to Participate in April Investor Conferences • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update • GlobeNewswire Inc. • 03/14/2024 08:00:00 PM
- aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants • GlobeNewswire Inc. • 02/21/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:20:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:15:45 AM
- aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity • GlobeNewswire Inc. • 01/29/2024 01:00:00 PM
- aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor • GlobeNewswire Inc. • 01/18/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:35:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:30:22 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/02/2024 05:21:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 11:50:14 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/21/2023 05:15:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2023 09:11:52 PM
- aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023 • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/09/2023 10:01:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/09/2023 09:42:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:11:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:06:34 PM
- aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update • GlobeNewswire Inc. • 11/09/2023 09:00:00 PM
- aTyr Pharma to Present at November Investor Conferences • GlobeNewswire Inc. • 11/01/2023 12:00:00 PM
- aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD • GlobeNewswire Inc. • 10/31/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 01:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 12:04:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM